ArticleClinical drug investigation2024

Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in Japan.

Chanon Nusawat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.